Vironexis Biotherapeutics

Austin, TX · Founded 2021 · Privately Held (backing)

Developer of a cancer treatment biotechnology designed to offer AAV-delivered T-cell Immunotherapy. Vironexis Biotherapeutics is based in Austin, TX and was founded in 2021. Its last reported valuation was $125 million in Feb 2025. It has raised $52 million.

Last reported valuation

$125.0M

Oct 2026

Priced at

—

Total raised

$52.0M

Last round

—

How much has Vironexis Biotherapeutics raised?

$52.0Macross 0 recorded rounds

Free account

More of Vironexis Biotherapeutics with a free account

·Watch Vironexis Biotherapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Vironexis Biotherapeutics investors

6 investors are on record for Vironexis Biotherapeutics, including Capital Factory, Drive Capital, Future Ventures (San Francisco) and Rev1 Ventures.

For fundraisers

Raising for a company like Vironexis Biotherapeutics?

6 investors have backed Vironexis Biotherapeutics.

See all 6 investors →

Frequently asked about Vironexis Biotherapeutics

How much has Vironexis Biotherapeutics raised?: Vironexis Biotherapeutics has raised $52.0M in total across 0 recorded funding rounds.